Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2011

01.11.2011 | Preclinical study

Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells

verfasst von: Nguyen Thi Thuy Phuong, Sang Kyum Kim, Sung Chul Lim, Hyung Sik Kim, Tae Hyung Kim, Kwang Yeol Lee, Sang-Gun Ahn, Jung-Hoon Yoon, Keon Wook Kang

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Tamoxifen (TAM) resistance is a serious clinical problem in the treatment of breast cancer. Here, we found that S-adenosylmethionine (SAM) and DNA methyltransferase1 (DNMT1) expression are up-regulated in TAM-resistant breast cancer (TAMR-MCF-7) cells. We further focused on whether increased SAM with DNMT1 overexpression in TAMR-MCF-7 cells lead to aberrant methylation of the PTEN gene promoter and its therapeutic potential. Methylation-specific PCR analyses revealed that two sites within the PTEN promoters were methylated in TAMR-MCF-7 cells, which resulted in down-regulation of PTEN expression and increase in Akt phosphorylation. Both the loss of PTEN expression and the increased Akt phosphorylation in TAMR-MCF-7 cells were completely reversed by 5-aza-2′-deoxycytidine (5-Aza), a DNMT inhibitor. 5-Aza inhibited the basal cell proliferation rate of TAMR-MCF-7 cells and intraperitoneal injection of 5-Aza significantly suppressed TAMR-MCF-7 tumor growth in a xenograft study. Immunohistochemistry showed that PTEN expression in TAM-resistant human breast cancer tissues was lower than in TAM-responsive cases. These results suggest that methylation of the PTEN promoter related to both SAM increase and DNMT1 activation contributes to persistent Akt activation and are potential therapeutic targets for reversing TAM resistance in breast cancer.
Literatur
1.
Zurück zum Zitat Mueller SO, Clark JA, Mvers PH, Korach KS (2002) Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinol 143:2357–2365CrossRef Mueller SO, Clark JA, Mvers PH, Korach KS (2002) Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinol 143:2357–2365CrossRef
2.
Zurück zum Zitat Petrangeli E, Lubrano C, Ortolani F et al (1994) Estrogen receptors: new perspectives in breast cancer management. J Steroid Biochem Mol Biol 49:327–331PubMedCrossRef Petrangeli E, Lubrano C, Ortolani F et al (1994) Estrogen receptors: new perspectives in breast cancer management. J Steroid Biochem Mol Biol 49:327–331PubMedCrossRef
3.
Zurück zum Zitat Rose C, Thorpe SM, Andersen KW, Pedersen BV, Mouridsen HT, Blichert-Toft M, Rasmussen BB (1985) Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1:16–19PubMedCrossRef Rose C, Thorpe SM, Andersen KW, Pedersen BV, Mouridsen HT, Blichert-Toft M, Rasmussen BB (1985) Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1:16–19PubMedCrossRef
4.
Zurück zum Zitat Eiermann W, Paepke S, Appfelstaedt J, Llombart-Cussac A, Eremin J, Vinholes J, Mauriac L, Ellis M, Lassus M, Chaudri-Ross HA, Dugan M, Borgs M (2001) Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol 12:1527–1532PubMedCrossRef Eiermann W, Paepke S, Appfelstaedt J, Llombart-Cussac A, Eremin J, Vinholes J, Mauriac L, Ellis M, Lassus M, Chaudri-Ross HA, Dugan M, Borgs M (2001) Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol 12:1527–1532PubMedCrossRef
5.
Zurück zum Zitat Clemons M, Danson S, Howell A (2002) Tamoxifen (“Nolvadex”): a review. Cancer Treat Rev 28:165–180PubMedCrossRef Clemons M, Danson S, Howell A (2002) Tamoxifen (“Nolvadex”): a review. Cancer Treat Rev 28:165–180PubMedCrossRef
6.
Zurück zum Zitat Ali S, Coombes RC (2002) Endocrine-responsive breast cancer cell and strategies for combating resistance. Nat Rev Cancer 2:101–112PubMedCrossRef Ali S, Coombes RC (2002) Endocrine-responsive breast cancer cell and strategies for combating resistance. Nat Rev Cancer 2:101–112PubMedCrossRef
7.
Zurück zum Zitat Osborne CK, Fuqua SA (1994) Mechanism of tamoxifen resistance. Breast Cancer Res Treat 32:49–55PubMedCrossRef Osborne CK, Fuqua SA (1994) Mechanism of tamoxifen resistance. Breast Cancer Res Treat 32:49–55PubMedCrossRef
8.
Zurück zum Zitat Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI (2003) Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediated an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinol 144:1032–1044CrossRef Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI (2003) Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediated an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinol 144:1032–1044CrossRef
9.
Zurück zum Zitat Choi HK, Yang JW, Roh SH, Han CY, Kang KW (2007) Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells. Endocr Relat Cancer 14:293–303PubMedCrossRef Choi HK, Yang JW, Roh SH, Han CY, Kang KW (2007) Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells. Endocr Relat Cancer 14:293–303PubMedCrossRef
10.
Zurück zum Zitat Lu SC, Mato JM (2005) Role of methionine adenosyltransferase and SAMe in alcohol-associated liver cancer. Alcohol 35:227–234PubMedCrossRef Lu SC, Mato JM (2005) Role of methionine adenosyltransferase and SAMe in alcohol-associated liver cancer. Alcohol 35:227–234PubMedCrossRef
11.
Zurück zum Zitat Mato JM, Alvarez L, Ortiz P, Pajares MA (1997) S-adenosylmethionine synthesis: molecular mechanism and clinical implications. Pharmacol Ther 73:265–280PubMedCrossRef Mato JM, Alvarez L, Ortiz P, Pajares MA (1997) S-adenosylmethionine synthesis: molecular mechanism and clinical implications. Pharmacol Ther 73:265–280PubMedCrossRef
12.
Zurück zum Zitat Mato JM, Lu SC (2007) Role of S-adenosyl-l-methionine in liver health and injury. Hepatology 45:1306–1312PubMedCrossRef Mato JM, Lu SC (2007) Role of S-adenosyl-l-methionine in liver health and injury. Hepatology 45:1306–1312PubMedCrossRef
13.
Zurück zum Zitat Lu SC, Mato JM (2008) S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol 23:S73–S77PubMedCrossRef Lu SC, Mato JM (2008) S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol 23:S73–S77PubMedCrossRef
14.
Zurück zum Zitat Mudd SH, Poole JR (1975) Labile methyl balances for normal humans of various dietary regimens. Metabolism 24:721–735PubMedCrossRef Mudd SH, Poole JR (1975) Labile methyl balances for normal humans of various dietary regimens. Metabolism 24:721–735PubMedCrossRef
15.
Zurück zum Zitat Tobena R, Horikawa S, Calvo V, Alemany S (1996) Interleukin-2 induces-S-adenosyl-l-methionine synthetase gene expression during T lymphocyte activation. Biochem J 319:929–933PubMed Tobena R, Horikawa S, Calvo V, Alemany S (1996) Interleukin-2 induces-S-adenosyl-l-methionine synthetase gene expression during T lymphocyte activation. Biochem J 319:929–933PubMed
16.
Zurück zum Zitat Ansorena E, García-Trevijano ER, Martínez-Chantar ML, Huang ZZ, Chen L, Mato JM, Iraburu M, Lu SC, Avila MA (2002) S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology 35(2):274–280PubMedCrossRef Ansorena E, García-Trevijano ER, Martínez-Chantar ML, Huang ZZ, Chen L, Mato JM, Iraburu M, Lu SC, Avila MA (2002) S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology 35(2):274–280PubMedCrossRef
17.
Zurück zum Zitat Zhao Y, Li JS, Guo MZ, Feng BS, Zhang JP (2010) Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. Chin J Cancer 29:752–760PubMed Zhao Y, Li JS, Guo MZ, Feng BS, Zhang JP (2010) Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. Chin J Cancer 29:752–760PubMed
18.
Zurück zum Zitat Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, Sodir NM, Chen YH, Josef-Lenz H, Laird PW, Clarke S, Mato JM, Lu SC (2007) Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 133:207–218PubMedCrossRef Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, Sodir NM, Chen YH, Josef-Lenz H, Laird PW, Clarke S, Mato JM, Lu SC (2007) Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 133:207–218PubMedCrossRef
19.
Zurück zum Zitat Luzhna L, Kovalchuk O (2010) Modulation of DNA methylation levels sensitizes doxorubicin-resistant breast adenocarcinoma cells to radiation-induced apoptosis. Biochem Biophys Res Commun 392:113–117PubMedCrossRef Luzhna L, Kovalchuk O (2010) Modulation of DNA methylation levels sensitizes doxorubicin-resistant breast adenocarcinoma cells to radiation-induced apoptosis. Biochem Biophys Res Commun 392:113–117PubMedCrossRef
20.
Zurück zum Zitat Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:245–254PubMedCrossRef Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:245–254PubMedCrossRef
21.
Zurück zum Zitat Pecorino L (2005) Molecular biology of cancer. Chap 3: Regulation of gene expression. Oxford University Press, New York Pecorino L (2005) Molecular biology of cancer. Chap 3: Regulation of gene expression. Oxford University Press, New York
22.
Zurück zum Zitat Vanyushin BF, Tkacheva SG, Belozersky AN (1970) Rare bases in animal DNA. Nature 225:948–949PubMedCrossRef Vanyushin BF, Tkacheva SG, Belozersky AN (1970) Rare bases in animal DNA. Nature 225:948–949PubMedCrossRef
23.
Zurück zum Zitat Antequera F, Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90:11995–11999PubMedCrossRef Antequera F, Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90:11995–11999PubMedCrossRef
24.
Zurück zum Zitat Bird AP (1995) Gene number, noise reduction and biological complexity. Trends Genet 11:94–100PubMedCrossRef Bird AP (1995) Gene number, noise reduction and biological complexity. Trends Genet 11:94–100PubMedCrossRef
25.
Zurück zum Zitat Yang H, Huang ZZ, Wang J, Lu SC (2001) The role of c-Myb and Sp1 in the upregulation of methionine adenosyltransferase 2A gene expression in human hepatocelluar carcinoma. FASEB J 15:1507–1516PubMedCrossRef Yang H, Huang ZZ, Wang J, Lu SC (2001) The role of c-Myb and Sp1 in the upregulation of methionine adenosyltransferase 2A gene expression in human hepatocelluar carcinoma. FASEB J 15:1507–1516PubMedCrossRef
26.
Zurück zum Zitat Rhee I, Bachman KE, Park BH, Jair KW et al (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nat 416:552–556CrossRef Rhee I, Bachman KE, Park BH, Jair KW et al (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nat 416:552–556CrossRef
27.
28.
Zurück zum Zitat Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M (2004) PI3K/AKT signalling pathway and cancer. Cancer Treat Rev 30:193–204PubMedCrossRef Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M (2004) PI3K/AKT signalling pathway and cancer. Cancer Treat Rev 30:193–204PubMedCrossRef
29.
Zurück zum Zitat Samuels Y, Ericson K (2006) Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18:77–82PubMedCrossRef Samuels Y, Ericson K (2006) Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18:77–82PubMedCrossRef
30.
Zurück zum Zitat Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39PubMedCrossRef Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39PubMedCrossRef
31.
Zurück zum Zitat Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA, Das S (2001) PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 91:22–26PubMedCrossRef Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA, Das S (2001) PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 91:22–26PubMedCrossRef
32.
Zurück zum Zitat Mir Mohammad Sadegh A, Marini A, Nambiar S, Hassan M, Tannapfel A, Ruzicka T, Hengge UR (2006) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 66:6546–6552CrossRef Mir Mohammad Sadegh A, Marini A, Nambiar S, Hassan M, Tannapfel A, Ruzicka T, Hengge UR (2006) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 66:6546–6552CrossRef
33.
Zurück zum Zitat Soria JC, Lee HY, Khuri FR et al (2002) Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 8:1178–1184PubMed Soria JC, Lee HY, Khuri FR et al (2002) Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 8:1178–1184PubMed
34.
Zurück zum Zitat Roman-Gomez J, Jimenez-Velasco A, Torres A et al (2004) Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104:2492–2498PubMedCrossRef Roman-Gomez J, Jimenez-Velasco A, Torres A et al (2004) Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104:2492–2498PubMedCrossRef
35.
Zurück zum Zitat Wiencke JK, Zheng S, Stokoe D et al (2007) Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol 9:271–279PubMedCrossRef Wiencke JK, Zheng S, Stokoe D et al (2007) Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol 9:271–279PubMedCrossRef
36.
Zurück zum Zitat Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000PubMed Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000PubMed
37.
Zurück zum Zitat Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY (2002) Epstein-Barr viruspositive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160:787–794PubMedCrossRef Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY (2002) Epstein-Barr viruspositive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160:787–794PubMedCrossRef
38.
Zurück zum Zitat Furuta J, Umebayashi Y, Miyamoto K, Kikuchi K, Otsuka F, Sugimura T, Ushijima T (2004) Promoter methylation profiling of 30 genes in human malignant melanoma. Cancer Sci 95:962–968PubMedCrossRef Furuta J, Umebayashi Y, Miyamoto K, Kikuchi K, Otsuka F, Sugimura T, Ushijima T (2004) Promoter methylation profiling of 30 genes in human malignant melanoma. Cancer Sci 95:962–968PubMedCrossRef
39.
Zurück zum Zitat Hou P, Ji M, Xing M (2008) Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/Akt signaling pathway in thyroid tumors. Cancer 113:2440–2447PubMedCrossRef Hou P, Ji M, Xing M (2008) Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/Akt signaling pathway in thyroid tumors. Cancer 113:2440–2447PubMedCrossRef
40.
Zurück zum Zitat Khan S, Kumagai T, Vora J, Bose N, Sehgal I, Koeffler PH, Bose S (2004) Pten promoter is methylated in a proportion invasive breast cancer. Int J Cancer 112:407–410PubMedCrossRef Khan S, Kumagai T, Vora J, Bose N, Sehgal I, Koeffler PH, Bose S (2004) Pten promoter is methylated in a proportion invasive breast cancer. Int J Cancer 112:407–410PubMedCrossRef
41.
Zurück zum Zitat Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermythylation of PTEN gene in gastric carcinoma. Cancer Res 69:2766–2774PubMedCrossRef Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermythylation of PTEN gene in gastric carcinoma. Cancer Res 69:2766–2774PubMedCrossRef
42.
Zurück zum Zitat She QB, Nagao I, Hayakawa T, Tsuge H (1994) A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem Biophys Res Commun 205:1748–1754PubMedCrossRef She QB, Nagao I, Hayakawa T, Tsuge H (1994) A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem Biophys Res Commun 205:1748–1754PubMedCrossRef
43.
Zurück zum Zitat Ahn MY, Chung HY, Choi WS, Lee BM, Yoon S, Kim HS (2010) Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4. Int J Oncol 36:125–131PubMed Ahn MY, Chung HY, Choi WS, Lee BM, Yoon S, Kim HS (2010) Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4. Int J Oncol 36:125–131PubMed
44.
Zurück zum Zitat Sowinska A, Jagodzinski PP (2007) RNA interference-mediated knockdown of DNMT1 and DNMT3b induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines. Cancer Lett 355:153–159CrossRef Sowinska A, Jagodzinski PP (2007) RNA interference-mediated knockdown of DNMT1 and DNMT3b induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines. Cancer Lett 355:153–159CrossRef
45.
Zurück zum Zitat Frogne T, Jepsen JS, Larsen SS, Fog CK, Brockdorff BL, Lykkesfeldt AE (2005) Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth. Endocr Relat Cancer 12:599–614PubMedCrossRef Frogne T, Jepsen JS, Larsen SS, Fog CK, Brockdorff BL, Lykkesfeldt AE (2005) Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth. Endocr Relat Cancer 12:599–614PubMedCrossRef
46.
Zurück zum Zitat Sabnis G, Goloubeva O, Jelovac D, Schayowitz A, Brodie A (2007) Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens. Clin Cancer Res 13:2751–2757PubMedCrossRef Sabnis G, Goloubeva O, Jelovac D, Schayowitz A, Brodie A (2007) Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens. Clin Cancer Res 13:2751–2757PubMedCrossRef
48.
Zurück zum Zitat Yang X, Yan Y, Davidson NE (2001) DNA methylation in breast cancer. Endocr Relat Cancer 8:115–127PubMedCrossRef Yang X, Yan Y, Davidson NE (2001) DNA methylation in breast cancer. Endocr Relat Cancer 8:115–127PubMedCrossRef
49.
Zurück zum Zitat Altundag O, Altundag K, Gunduz M (2004) DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients. Med Hypotheses 63:684–687PubMedCrossRef Altundag O, Altundag K, Gunduz M (2004) DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients. Med Hypotheses 63:684–687PubMedCrossRef
51.
Zurück zum Zitat Champe PC, Harvey RA (2008) Biochemistry. Lippincott’s illustrated reviews, 4th edn. Lippincott Williams and Wilkins, Hagerstown Champe PC, Harvey RA (2008) Biochemistry. Lippincott’s illustrated reviews, 4th edn. Lippincott Williams and Wilkins, Hagerstown
52.
Zurück zum Zitat Kim SK, Yang JW, Kim MR, Roh SH, Kim HG, Lee KY, Jeong HG, Kang KW (2008) Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Rad Biol Med 45:537–546PubMedCrossRef Kim SK, Yang JW, Kim MR, Roh SH, Kim HG, Lee KY, Jeong HG, Kang KW (2008) Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Rad Biol Med 45:537–546PubMedCrossRef
53.
Zurück zum Zitat Fry MJ (2001) Phosphoinositide 3-kinase signaling in breast cancer: how big a role might it play? Breast Cancer Res 3:304–312PubMedCrossRef Fry MJ (2001) Phosphoinositide 3-kinase signaling in breast cancer: how big a role might it play? Breast Cancer Res 3:304–312PubMedCrossRef
54.
Zurück zum Zitat Ahmad S, Singh N, Glazer RI (1999) Role of Akt1 in 17β-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 58:425–430PubMedCrossRef Ahmad S, Singh N, Glazer RI (1999) Role of Akt1 in 17β-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 58:425–430PubMedCrossRef
55.
Zurück zum Zitat Jordan NJ, Gee JM, Barrow D, Wakeling AE, Nicholson RI (2004) Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Res Treat 87:167–180PubMedCrossRef Jordan NJ, Gee JM, Barrow D, Wakeling AE, Nicholson RI (2004) Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Res Treat 87:167–180PubMedCrossRef
56.
Zurück zum Zitat Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine/threonine kinase akt/PKB. Exp Cell Res 253:210–229PubMedCrossRef Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine/threonine kinase akt/PKB. Exp Cell Res 253:210–229PubMedCrossRef
57.
Zurück zum Zitat El-Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, Baylin SB (1991) High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88:3470–3474PubMedCrossRef El-Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, Baylin SB (1991) High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88:3470–3474PubMedCrossRef
58.
Zurück zum Zitat De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG (1999) Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res 59:3855–3860PubMed De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG (1999) Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res 59:3855–3860PubMed
59.
Zurück zum Zitat Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR, Baylin SB (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85:1235–1240PubMedCrossRef Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR, Baylin SB (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85:1235–1240PubMedCrossRef
60.
Zurück zum Zitat Ramchandani S, MacLeod AR, Pinard M, von Hofe E, Szyf M (1997) Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci USA 94:684–689PubMedCrossRef Ramchandani S, MacLeod AR, Pinard M, von Hofe E, Szyf M (1997) Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci USA 94:684–689PubMedCrossRef
61.
Zurück zum Zitat Sahin M, Sahin E, Gumuslu S, Erdogan A, Gultekin M (2010) DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability. Cancer Metastasis Rev 29:655–676PubMedCrossRef Sahin M, Sahin E, Gumuslu S, Erdogan A, Gultekin M (2010) DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability. Cancer Metastasis Rev 29:655–676PubMedCrossRef
62.
Zurück zum Zitat Satini V, Kantarjian HM, Issa JP (2001) Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134:573–586 Satini V, Kantarjian HM, Issa JP (2001) Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134:573–586
63.
Zurück zum Zitat Cui M, Wen Z, Chen J, Yang Z, Zhang H (2010) 5-Aza-2′-deoxycytidine is a potent inhibitor of DNA methyltransferase 3B and induces apoptosis in human endometrial cancer cell lines with the up-regulation of hMLH1. Med Oncol 27:278–285PubMedCrossRef Cui M, Wen Z, Chen J, Yang Z, Zhang H (2010) 5-Aza-2′-deoxycytidine is a potent inhibitor of DNA methyltransferase 3B and induces apoptosis in human endometrial cancer cell lines with the up-regulation of hMLH1. Med Oncol 27:278–285PubMedCrossRef
Metadaten
Titel
Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells
verfasst von
Nguyen Thi Thuy Phuong
Sang Kyum Kim
Sung Chul Lim
Hyung Sik Kim
Tae Hyung Kim
Kwang Yeol Lee
Sang-Gun Ahn
Jung-Hoon Yoon
Keon Wook Kang
Publikationsdatum
01.11.2011
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2011
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-1304-2

Weitere Artikel der Ausgabe 1/2011

Breast Cancer Research and Treatment 1/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.